Education
About Us
Working with TipRanks
Follow Us
Todd E. Simpson Insider Profile
4 Followers
Todd E. Simpson, CFO at Seattle Genetics, holds 118.77K shares in Seattle Genetics (Ticker: SGEN), holds 0.00 shares in Neoleukin Therapeutics (Ticker: NLTX), holds ― shares in Tecogen (Ticker: TGEN). Most recently, Todd E. Simpson Sold ― shares of Seattle Genetics on Nov 09, 2020 for an estimated value of $1.35M.
Profitable Transactions
4 out of 7 Profitable Transactions
Average Return
+2.80%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Todd E. Simpson holds in companies
Most Profitable Insider Trade
The most profitable trade made by Todd E. Simpson
Todd E. Simpson's Trading History
Seattle Genetics
Nov 09, 2020
CFO
Informative Sell
1.35M
$20.09M
Neoleukin Therapeutics
―
Director
―
$0.00
Tecogen
―
VP, CFO, Treas. & Sec.
―
―
List of latest transactions for each holding click on a transaction to see Todd E. Simpson's performance on stock
You May Also Like
Todd E. Simpson insider profile FAQ
What is the percentage of profitable transactions made by Todd E. Simpson?
The percentage of profitable transactions made by Todd E. Simpson is 57%.
What is the average return per transaction made by Todd E. Simpson?
The average return per transaction made by Todd E. Simpson is 2.80%.
What stocks does Todd E. Simpson hold?
Todd E. Simpson holds: SGEN, NLTX, TGEN stocks.
What was Todd E. Simpson’s latest transaction?
Todd E. Simpson latest transaction was an Informative Sell of $1.35M.
What was Todd E. Simpson's most profitable transaction?
Todd E. Simpson’s most profitable transaction was an Informative Buy of SGEN stock on July 20, 2011. The return on the trade was 48.50%.
What is Todd E. Simpson's role in Seattle Genetics?
Todd E. Simpson's role in Seattle Genetics is CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.